{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T22:57:07Z","timestamp":1787871427286,"version":"build-2784847793"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,6]],"date-time":"2021-03-06T00:00:00Z","timestamp":1614988800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["MR\/K0019494\/1"],"award-info":[{"award-number":["MR\/K0019494\/1"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000735","name":"University of Cambridge","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MC_PC_13030"],"award-info":[{"award-number":["MC_PC_13030"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/R023026\/1"],"award-info":[{"award-number":["MR\/R023026\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["PO 4050281695"],"award-info":[{"award-number":["PO 4050281695"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MC_UU_00014\/5"],"award-info":[{"award-number":["MC_UU_00014\/5"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["C18342\/A23390"],"award-info":[{"award-number":["C18342\/A23390"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MC UP A90 1006"],"award-info":[{"award-number":["MC UP A90 1006"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/K0019494\/1"],"award-info":[{"award-number":["MR\/K0019494\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002926","name":"Cambridge University Hospitals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002926","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"BHF","doi-asserted-by":"publisher","award":["RG\/18\/7\/33636"],"award-info":[{"award-number":["RG\/18\/7\/33636"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010688","name":"Horizon 2020 European Innovation Council Fast Track to Innovation","doi-asserted-by":"publisher","award":["634413"],"award-info":[{"award-number":["634413"]}],"id":[{"id":"10.13039\/100010688","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C18342\/A23390"],"award-info":[{"award-number":["C18342\/A23390"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004282","name":"Evelyn Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004282","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Metabolism"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.molmet.2021.101210","type":"journal-article","created":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T17:28:34Z","timestamp":1616088514000},"page":"101210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"special_numbering":"C","title":["Suppression of insulin-induced gene 1 (INSIG1) function promotes hepatic lipid remodelling and restrains NASH progression"],"prefix":"10.1016","volume":"48","author":[{"given":"Vian","family":"Azzu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Vacca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Kamzolas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Leslie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Carobbio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Virtue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes","family":"Lukasik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Dale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Bohlooly-Y","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Animesh","family":"Acharjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Lind\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Bidault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelia","family":"Petsalaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian L.","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Oakley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.D.","family":"Allison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Vidal-Puig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.molmet.2021.101210_bib1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/liv.13299","article-title":"The epidemiology of non-alcoholic fatty liver disease","volume":"37","author":"Bellentani","year":"2017","journal-title":"Liver International"},{"issue":"2","key":"10.1016\/j.molmet.2021.101210_bib2","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jhep.2009.03.019","article-title":"Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis","volume":"51","author":"Argo","year":"2009","journal-title":"Journal of Hepatology"},{"issue":"4","key":"10.1016\/j.molmet.2021.101210_bib3","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jhep.2008.06.018","article-title":"Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease","volume":"49","author":"Ong","year":"2008","journal-title":"Journal of Hepatology"},{"issue":"6","key":"10.1016\/j.molmet.2021.101210_bib4","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","article-title":"Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis","volume":"10","author":"Anstee","year":"2013","journal-title":"Nature Reviews Gastroenterology & Hepatology"},{"issue":"2","key":"10.1016\/j.molmet.2021.101210_bib5","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/hep.30254","article-title":"Burden of illness and economic model for patients with nonalcoholic steatohepatitis in the United States","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.molmet.2021.101210_bib6","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1053\/j.gastro.2019.12.054","article-title":"Adipose tissue-liver cross talk in the control of whole-body metabolism: implications in nonalcoholic fatty liver disease","volume":"158","author":"Azzu","year":"2020","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.molmet.2021.101210_bib7","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1002\/hep.23229","article-title":"The plasma lipidomic signature of nonalcoholic steatohepatitis","volume":"50","author":"Puri","year":"2009","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.molmet.2021.101210_bib8","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13059-018-1439-8","article-title":"Hepatic steatosis risk is partly driven by increased de novo lipogenesis following carbohydrate consumption","volume":"19","author":"Sanders","year":"2018","journal-title":"Genome Biology"},{"issue":"8","key":"10.1016\/j.molmet.2021.101210_bib9","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.2337\/dc18-0071","article-title":"Saturated fat is more metabolically harmful for the human liver than unsaturated fat or simple sugars","volume":"41","author":"Luukkonen","year":"2018","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.molmet.2021.101210_bib10","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.molmet.2021.101210_bib11","doi-asserted-by":"crossref","first-page":"46658","DOI":"10.1038\/srep46658","article-title":"Metabolism dysregulation induces a specific lipid signature of nonalcoholic steatohepatitis in patients","volume":"7","author":"Chiappini","year":"2017","journal-title":"Scientific Reports"},{"issue":"4","key":"10.1016\/j.molmet.2021.101210_bib12","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/hep.28953","article-title":"Lipid zonation and phospholipid remodeling in nonalcoholic fatty liver disease","volume":"65","author":"Hall","year":"2017","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.molmet.2021.101210_bib13","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/hep.26604","article-title":"Free cholesterol accumulation in hepatic stellate cells: mechanism of liver fibrosis aggravation in nonalcoholic steatohepatitis in mice","volume":"59","author":"Tomita","year":"2014","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.molmet.2021.101210_bib14","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1055\/s-0035-1562945","article-title":"Fatty acid and glucose sensors in hepatic lipid metabolism: implications in NAFLD","volume":"35","author":"Vacca","year":"2015","journal-title":"Seminars in Liver Disease"},{"issue":"11","key":"10.1016\/j.molmet.2021.101210_bib15","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.2337\/db12-1748","article-title":"Adaptive changes of the Insig1\/SREBP1\/SCD1 set point help adipose tissue to cope with increased storage demands of obesity","volume":"62","author":"Carobbio","year":"2013","journal-title":"Diabetes"},{"issue":"18","key":"10.1016\/j.molmet.2021.101210_bib16","doi-asserted-by":"crossref","first-page":"7106","DOI":"10.1073\/pnas.0401715101","article-title":"Hepatic insig-1 or -2 overexpression reduces lipogenesis in obese Zucker diabetic fatty rats and in fasted\/refed normal rats","volume":"101","author":"Takaishi","year":"2004","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"9","key":"10.1016\/j.molmet.2021.101210_bib17","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1172\/JCI25614","article-title":"Schoenheimer effect explained--feedback regulation of cholesterol synthesis in mice mediated by Insig proteins","volume":"115","author":"Engelking","year":"2005","journal-title":"Journal of Clinical Investigation"},{"issue":"1","key":"10.1016\/j.molmet.2021.101210_bib18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1097-2765(02)00822-5","article-title":"Accelerated degradation of HMG CoA reductase mediated by binding of insig-1 to its sterol-sensing domain","volume":"11","author":"Sever","year":"2003","journal-title":"Molecular Cell"},{"issue":"9","key":"10.1016\/j.molmet.2021.101210_bib19","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","article-title":"Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions","volume":"94","author":"Brunt","year":"1999","journal-title":"American Journal of Gastroenterology"},{"issue":"6","key":"10.1016\/j.molmet.2021.101210_bib20","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.molmet.2021.101210_bib21","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1002\/hep.25889","article-title":"Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients","volume":"56","author":"Bedossa","year":"2012","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.molmet.2021.101210_bib22","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1177\/0023677213516312","article-title":"FELASA recommendations for the health monitoring of mouse, rat, hamster, Guinea pig and rabbit colonies in breeding and experimental units","volume":"48","author":"Felasa working group on revision of guidelines for health monitoring of rodents","year":"2014","journal-title":"Lab Animal"},{"issue":"8","key":"10.1016\/j.molmet.2021.101210_bib23","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1172\/JCI20978","article-title":"Overexpression of Insig-1 in the livers of transgenic mice inhibits SREBP processing and reduces insulin-stimulated lipogenesis","volume":"113","author":"Engelking","year":"2004","journal-title":"Journal of Clinical Investigation"},{"issue":"12","key":"10.1016\/j.molmet.2021.101210_bib24","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1172\/JCI5341","article-title":"Blunted feedback suppression of SREBP processing by dietary cholesterol in transgenic mice expressing sterol-resistant SCAP(D443N)","volume":"102","author":"Korn","year":"1998","journal-title":"Journal of Clinical Investigation"},{"issue":"42","key":"10.1016\/j.molmet.2021.101210_bib25","doi-asserted-by":"crossref","first-page":"30028","DOI":"10.1074\/jbc.274.42.30028","article-title":"Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus","volume":"274","author":"Shimomura","year":"1999","journal-title":"Journal of Biological Chemistry"},{"issue":"4","key":"10.1016\/j.molmet.2021.101210_bib26","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jhep.2008.12.016","article-title":"Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH","volume":"50","author":"Caballero","year":"2009","journal-title":"Journal of Hepatology"},{"issue":"5","key":"10.1016\/j.molmet.2021.101210_bib27","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1440-1746.2011.06704.x","article-title":"SREBP-2: a link between insulin resistance, hepatic cholesterol, and inflammation in NASH","volume":"26","author":"Van Rooyen","year":"2011","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"6","key":"10.1016\/j.molmet.2021.101210_bib28","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1172\/JCI41636","article-title":"The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans","volume":"122","author":"Benhamed","year":"2012","journal-title":"Journal of Clinical Investigation"},{"issue":"1","key":"10.1016\/j.molmet.2021.101210_bib29","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.molcel.2019.01.036","article-title":"Probing the global cellular responses to lipotoxicity caused by saturated fatty acids","volume":"74","author":"Piccolis","year":"2019","journal-title":"Molecular Cell"},{"issue":"3","key":"10.1016\/j.molmet.2021.101210_bib30","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jhep.2016.05.005","article-title":"A\u00a0diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer","volume":"65","author":"Asgharpour","year":"2016","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.molmet.2021.101210_bib31","series-title":"Encyclopedia of biological chemistry","first-page":"281","article-title":"Fatty acid oxidation","author":"Schulz","year":"2013"},{"issue":"2","key":"10.1016\/j.molmet.2021.101210_bib32","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41575-019-0210-2","article-title":"Adaptive immunity: an emerging player in the progression of NAFLD","volume":"17","author":"Sutti","year":"2020","journal-title":"Nature Reviews Gastroenterology & Hepatology"},{"issue":"4","key":"10.1016\/j.molmet.2021.101210_bib33","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/hep.29544","article-title":"Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis","volume":"67","author":"Krenkel","year":"2018","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.molmet.2021.101210_bib34","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/hep.26783","article-title":"Pharmacological inhibition of the chemokine C-C motif chemokine ligand 2 (monocyte chemoattractant protein 1) accelerates liver fibrosis regression by suppressing Ly-6C(+) macrophage infiltration in mice","volume":"59","author":"Baeck","year":"2014","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.molmet.2021.101210_bib35","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/hep.31391","article-title":"Lipid remodelling in hepatocyte proliferation and hepatocellular carcinoma","volume":"73","author":"Hall","year":"2020","journal-title":"Hepatology"},{"issue":"46","key":"10.1016\/j.molmet.2021.101210_bib36","first-page":"E3186","article-title":"Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis","volume":"109","author":"Ramachandran","year":"2012","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2 Suppl 1","key":"10.1016\/j.molmet.2021.101210_bib37","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1002\/hep.20969","article-title":"Liver regeneration","volume":"43","author":"Fausto","year":"2006","journal-title":"Hepatology"},{"issue":"1\u20132","key":"10.1016\/j.molmet.2021.101210_bib38","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.mce.2012.06.025","article-title":"Nuclear receptors in regenerating liver and hepatocellular carcinoma","volume":"368","author":"Vacca","year":"2013","journal-title":"Molecular and Cellular Endocrinology"},{"issue":"4","key":"10.1016\/j.molmet.2021.101210_bib39","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/hep.26222","article-title":"Hepatic-specific activation of peroxisome proliferator-activated receptor gamma coactivator-1beta protects against steatohepatitis","volume":"57","author":"Bellafante","year":"2013","journal-title":"Hepatology"},{"issue":"33","key":"10.1016\/j.molmet.2021.101210_bib40","doi-asserted-by":"crossref","first-page":"13765","DOI":"10.1073\/pnas.0904246106","article-title":"Genome-wide analysis of SREBP-1 binding in mouse liver chromatin reveals a preference for promoter proximal binding to a new motif","volume":"106","author":"Seo","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.molmet.2021.101210_bib41","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev-pathol-012615-044224","article-title":"Nonalcoholic fatty liver disease: pathogenesis and disease spectrum","volume":"11","author":"Hardy","year":"2016","journal-title":"Annual Review of Pathology: Mechanisms of Disease"},{"issue":"6","key":"10.1016\/j.molmet.2021.101210_bib42","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41575-018-0009-6","article-title":"Triggering and resolution of inflammation in NASH","volume":"15","author":"Schuster","year":"2018","journal-title":"Nature Reviews Gastroenterology & Hepatology"},{"issue":"3","key":"10.1016\/j.molmet.2021.101210_bib43","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/j.gastro.2013.11.049","article-title":"Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease","volume":"146","author":"Lambert","year":"2014","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.molmet.2021.101210_bib44","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/hep.21763","article-title":"A\u00a0lipidomic analysis of nonalcoholic fatty liver disease","volume":"46","author":"Puri","year":"2007","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.molmet.2021.101210_bib45","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1016\/j.cgh.2018.04.042","article-title":"Acetyl-CoA carboxylase inhibitor GS-0976 for 12 Weeks reduces hepatic de novo lipogenesis and steatosis in patients with nonalcoholic steatohepatitis","volume":"16","author":"Lawitz","year":"2018","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"1","key":"10.1016\/j.molmet.2021.101210_bib46","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/hep4.1443","article-title":"Farnesoid X receptor agonism, acetyl-coenzyme A carboxylase inhibition, and back translation of clinically observed endpoints of de novo lipogenesis in a murine NASH model","volume":"4","author":"Gapp","year":"2020","journal-title":"Hepatology Communications"},{"issue":"12","key":"10.1016\/j.molmet.2021.101210_bib47","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1016\/j.febslet.2010.04.004","article-title":"An allostatic control of membrane lipid composition by SREBP1","volume":"584","author":"Hagen","year":"2010","journal-title":"FEBS Letters"},{"issue":"9","key":"10.1016\/j.molmet.2021.101210_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20092167","article-title":"Membrane lipid composition: effect on membrane and organelle structure, function and compartmentalization and therapeutic avenues","volume":"20","author":"Casares","year":"2019","journal-title":"International Journal of Molecular Sciences"},{"issue":"3","key":"10.1016\/j.molmet.2021.101210_bib49","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1194\/jlr.P056002","article-title":"Biomarkers of NAFLD progression: a lipidomics approach to an epidemic","volume":"56","author":"Gorden","year":"2015","journal-title":"The Journal of Lipid Research"},{"issue":"5","key":"10.1016\/j.molmet.2021.101210_bib50","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.jhep.2016.01.002","article-title":"Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease","volume":"64","author":"Luukkonen","year":"2016","journal-title":"Journal of Hepatology"},{"issue":"4","key":"10.1016\/j.molmet.2021.101210_bib51","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1194\/jlr.M001404","article-title":"INSIG1 influences obesity-related hypertriglyceridemia in humans","volume":"51","author":"Smith","year":"2010","journal-title":"The Journal of Lipid Research"},{"issue":"1","key":"10.1016\/j.molmet.2021.101210_bib52","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s00125-006-0479-x","article-title":"Human evidence for the involvement of insulin-induced gene 1 in the regulation of plasma glucose concentration","volume":"50","author":"Krapivner","year":"2007","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.molmet.2021.101210_bib53","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3945\/ajcn.2010.29422","article-title":"No association between polymorphisms in the INSIG1 gene and the risk of type 2 diabetes and related traits","volume":"92","author":"Szopa","year":"2010","journal-title":"American Journal of Clinical Nutrition"},{"issue":"3","key":"10.1016\/j.molmet.2021.101210_bib54","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1194\/jlr.M081836","article-title":"Interplay between ChREBP and SREBP-1c coordinates postprandial glycolysis and lipogenesis in livers of mice","volume":"59","author":"Linden","year":"2018","journal-title":"The Journal of Lipid Research"},{"issue":"3","key":"10.1016\/j.molmet.2021.101210_bib55","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1152\/physiolgenomics.00139.2007","article-title":"Liver gene expression analysis reveals endoplasmic reticulum stress and metabolic dysfunction in SCD1-deficient mice fed a very low-fat diet","volume":"33","author":"Flowers","year":"2008","journal-title":"Physiological Genomics"},{"issue":"9","key":"10.1016\/j.molmet.2021.101210_bib56","doi-asserted-by":"crossref","first-page":"5637","DOI":"10.1074\/jbc.M807616200","article-title":"Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-CoA desaturase","volume":"284","author":"Li","year":"2009","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"10.1016\/j.molmet.2021.101210_bib57","doi-asserted-by":"crossref","first-page":"6489","DOI":"10.1038\/s41598-020-63579-3","article-title":"Hepatocyte-specific deletion of Pparalpha promotes NAFLD in the context of obesity","volume":"10","author":"Regnier","year":"2020","journal-title":"Scientific Reports"},{"issue":"Suppl 3","key":"10.1016\/j.molmet.2021.101210_bib58","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.2337\/diabetes.53.suppl_3.S6","article-title":"Metabolic syndrome and robustness tradeoffs","volume":"53","author":"Kitano","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2021.101210_bib59","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cellimm.2018.01.020","article-title":"Macrophages and lipid metabolism","volume":"330","author":"Remmerie","year":"2018","journal-title":"Cellular Immunology"},{"key":"10.1016\/j.molmet.2021.101210_bib60","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.3389\/fimmu.2017.01949","article-title":"The role of lipid metabolism in T lymphocyte differentiation and survival","volume":"8","author":"Howie","year":"2017","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.molmet.2021.101210_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jnutbio.2015.11.002","article-title":"Role of lipids in the metabolism and activation of immune cells","volume":"34","author":"Hubler","year":"2016","journal-title":"The Journal of Nutritional Biochemistry"},{"issue":"6","key":"10.1016\/j.molmet.2021.101210_bib62","doi-asserted-by":"crossref","first-page":"4959","DOI":"10.1074\/jbc.M410078200","article-title":"Adipogenic transcriptional regulation of hepatic stellate cells","volume":"280","author":"She","year":"2005","journal-title":"Journal of Biological Chemistry"}],"container-title":["Molecular Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877821000508?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877821000508?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T13:20:48Z","timestamp":1778851248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212877821000508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":62,"alternative-id":["S2212877821000508"],"URL":"https:\/\/doi.org\/10.1016\/j.molmet.2021.101210","relation":{},"ISSN":["2212-8778"],"issn-type":[{"value":"2212-8778","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Suppression of insulin-induced gene 1 (INSIG1) function promotes hepatic lipid remodelling and restrains NASH progression","name":"articletitle","label":"Article Title"},{"value":"Molecular Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmet.2021.101210","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"101210"}}